As Reported Financials

Document Name As Of Date Currency Code (in thousands) 2019 Y 10-K 12/31/2019 USD 2018 Y 10-K 12/31/2018 USD 2017 Y 10-K 12/31/2017 USD 2016 Y 10-K 12/31/2016 USD
Document Name As Of Date Currency Code 2019 Y 10-K 12/31/2019 USD 2018 Y 10-K 12/31/2018 USD 2017 Y 10-K 12/31/2017 USD 2016 Y 10-K 12/31/2016 USD

Operating Activities
Net income 92,728 45,563 71,876 204,329

Adjustments to reconcile net income to net cash provided by operating activities
Depreciation and amortization 123,314 131,722 127,744 115,357
Impairment charge 37,610 49,739 0 0
Amortization of deferred financing costs 3,004 3,058 3,263 3,237
Gain on sale of assets (43,422) 0 (6,943) (6,305)
Gain on previously held interest in acquired joint ventures NA NA NA (95,516)
Loss on early extinguishment of debt 0 0 35,626 0
Equity in earnings of unconsolidated joint ventures (7,839) (924) (1,937) (10,872)
Equity-based compensation expense 18,120 14,669 13,585 15,319
Amortization of debt (premiums) and discounts, net 448 416 462 1,290
Amortization (accretion) of market rent rate adjustments, net 1,432 2,577 2,829 3,302
Straight-line rent adjustments (7,721) (5,844) (5,632) (7,002)
Distributions of cumulative earnings from unconsolidated joint ventures 7,587 7,941 10,697 13,662
Other non-cash 3,638 0 0 NA
Changes in other asset and liabilities
Other assets (4,159) 2,079 365 (544)
Accounts payable and accrued expenses (4,288) 7,322 1,224 3,059
Net cash provided by operating activities 220,452 258,318 253,159 239,316

Investing Activities
Additions to rental property (47,884) (64,253) (166,231) (165,060)
Acquisitions of interest in unconsolidated joint ventures, net of cash acquired NA NA NA (45,219)
Additions to investments in unconsolidated joint ventures (2,316) (1,916) (5,892) (32,968)
Net proceeds on sale of assets 128,505 0 39,213 28,706
Distributions in excess of cumulative earnings from unconsolidated joint ventures 17,819 25,232 25,084 60,267
Additions to non-real estate assets (1,155) (1,330) (8,909) (6,503)
Additions to deferred lease costs (5,142) (6,703) (6,584) (7,013)
Other investing activities 9,462 8,947 5,774 983
Net cash provided by (used in) investing activities 99,289 (40,023) (117,545) (166,807)

Financing Activities
Cash dividends paid (132,664) (131,244) (130,166) (141,088)
Distributions to noncontrolling interests in Operating Partnership (7,018) (6,955) (6,800) (7,428)
Proceeds from revolving credit facility 282,870 491,900 719,521 845,650
Repayments of revolving credit facility (427,970) (554,900) (572,421) (974,950)
Proceeds from notes, mortgages and loans 0 25,000 299,460 437,420
Repayments of notes, mortgages and loans (3,369) (11,783) (373,258) (330,329)
Payment of make-whole premium related to early extinguishment of debt 0 0 (34,143) 0
Repayment of deferred financing obligation NA NA NA (28,388)
Repurchase of common shares, including transaction costs (20,000) (19,998) (49,361) 0
Employee income taxes paid related to shares withheld upon vesting of equity awards (2,524) (2,068) (2,436) (2,177)
Additions to deferred financing costs (115) (4,428) (2,850) (5,496)
Proceeds from exercise of options 0 0 54 1,749
Proceeds from other financing activities 47 626 12,054 3,897
Payment for other financing activities (1,390) (1,353) (1,333) (2,327)
Net cash used in financing activities (312,133) (215,203) (141,679) (203,467)
Effect of foreign currency rate changes on cash and cash equivalents (19) (110) (56) 316
Net increase (decrease) in cash, cash equivalents and restricted cash 7,589 2,982 (6,121) (130,642)
Cash and cash equivalents, beginning of period 9,083 6,101 12,222 142,864
Cash and cash equivalents, end of period 16,672 9,083 6,101 12,222
Data shown on this page is extracted directly from the company’s documents. S&P makes every effort to line up fields, captions and headers that represent the same data over time, despite variations in how the company may report these items in different documents. In certain instances the variation in the company’s presentation over time may be too significant, potentially resulting in repeating and/or disordered items. Despite possible issues with the presentation, S&P, as always, stands by its commitment to the quality of the data.